PropertyValue
?:abstract
  • Aims: Rising prevalence of non-communicable diseases world-wide has made diabetes an important comorbidity in patients with coronavirus disease-19 (COVID-19) We sought to review the risk, severity and mortality in COVID-19 and its relation to the glycemic control, and role of anti-diabetic agents in patients with diabetes
is ?:annotates of
?:creator
?:journal
  • Diabetes_Research_and_Clinical_Practice
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: a narrative review. (Special issue on diabetes and COVID-19: the IDF perspective.)
?:type
?:who_covidence_id
  • #912127
?:year
  • 2020

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/xgxko1jg>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/xgxko1jg>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all